Clinical Trial Update: Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of recombinant Timothy grass pollen allergens adsorbed to aluminum hydroxide for allergic rhinoconjunctivitis with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis
• Asthma

Drugs mentioned

• Timothy grass pollen recombinant major allergen immunotherapy adsorbed onto aluminium hydroxide (recombinant major allergens of Timothy grass pollen adsorbed onto aluminium hydroxide)

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Rhinoconjunctivitis | Phase 3 | Status: COMPLETED